Atlas Trials

Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Vismodegib Before Surgery in Pancreatic Cancer

Clinical trial NCT01713218 · UNKNOWN

Trial details

NCT number
NCT01713218
Sponsor
Jean-Luc Van Laethem
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma Resectable
Start date
2012-12-01
Primary completion
2014-06-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.